RDInvesting Provides Investors with Free In-Depth Equity Reports on INFA, SIMO, XLS and XYL


Follow this company

Companies Mentioned

NASDAQ:INFA / NASDAQ:SIMO / NYSE:XLS / NYSE:XYL
01/24/2014 [ACCESSWIRE]

Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at www.RDInvesting.com and get exclusive access to our numerous stock reports and market updates.

Informatica Corporation (NASDAQ: INFA) shares declined 1.36 percent to close at $42.90 a share Thursday. The stock traded between $42.50 and $43.24 on volume of 2.12 million shares traded. Analysts at Deutsche Bank have recently downgraded the company’s rating to "hold" from "buy". Shares of Informatica have gained approximately 30.0 percent in the past year.

Find out more about Informatica including full access to the free equity report at:       
www.RDInvesting.com/INFA

Silicon Motion Technology Corp. (NASDAQ: SIMO) shares increased 1.13 percent to close at $15.17 a share Thursday. The stock traded between $14.71 and $15.20 on volume of 434,487 shares traded. Analysts at Needham have recently upgraded the company’s rating to "buy" from "hold". Shares of Silicon Motion Technology have gained approximately 2.0 percent in the past year.

Find out more about Silicon Motion Technology including full access to the free equity report at:     
www.RDInvesting.com/SIMO

Exelis Inc. (NYSE: XLS) shares declined 1.63 percent to close at $20.46 a share Thursday. The stock traded between $20.39 and $20.71 on volume of 1.40 million shares traded. Analysts at Cowen have recently initiated coverage on the company with an "outperform" rating. Shares of Exelis have gained approximately 80.0 percent in the past year.

Find out more about Exelis including full access to the free equity report at:       
www.RDInvesting.com/XLS

Xylem Inc. (NYSE: XYL) shares declined 2.88 percent to close at $35.44 a share Thursday. The stock traded between $35.29 and $36.32 on volume of 1.03 million shares traded. Analysts at Oppenheimer have recently initiated coverage on the company with an "outperform" rating. Shares of Xylem have gained approximately 28.0 percent in the past year.

Find out more about Xylem including full access to the free equity report at:     
www.RDInvesting.com/XYL

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:             
Research Driven Investing        
info@rdinvesting.com

COMMENTS

Leave a comment...
 * 

Your Name
 *